GSK News and Press, GlaxoSmithKline PLC

2026-03-14 09:48:29 ET More on GSK, Amgen Amgen: MariTide And Osteoporosis Sales Fuel The Rally GSK plc (GSK) Presents at Barclays 28th Annual Global Healthcare Conference Transcript Amgen Inc. (AMGN) Presents at Leerink Global Healthcare Conference 2026 Transcript ...

In the US, an estimated 21 million adults under 50 have at least one risk factor for severe RSV infection 1 * GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has expanded the approved age indication of AREXVY (Respiratory Syncytial Virus Vacc...

2026-03-13 07:12:33 ET More on GSK, Agenus GSK plc (GSK) Presents at Barclays 28th Annual Global Healthcare Conference Transcript GSK: Post-Pivot Buoyancy Set To Continue After Strong 2025 (Upgrade) GSK plc 2025 Q4 - Results - Earnings Call Presentation GSK g...

2026-03-11 16:22:24 ET GSK plc (GSK) Barclays 28th Annual Global Healthcare Conference March 11, 2026 11:30 AM EDT... Read the full article on Seeking Alpha For further details see: GSK plc (GSK) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

2026-03-10 15:44:56 ET Introduction Read the full article on Seeking Alpha For further details see: Moderna: Pipeline Hope Won't Pay The Bills

2026-03-10 10:53:45 ET More on GSK GSK: Post-Pivot Buoyancy Set To Continue After Strong 2025 (Upgrade) GSK plc 2025 Q4 - Results - Earnings Call Presentation GSK plc (GSK) Q4 2025 Earnings Call Transcript Tylenol use in pregnancy fell after Trump’s au...

2026-03-07 07:41:45 ET More on Pfizer, Johnson & Johnson, etc. Pfizer: Obesity Hype And Vaccine Policy Shocks The Sun Will Shine On Moderna Again - Initiating With A Buy Why Moderna's $950M Patent Bill Is A Small Price For Pipeline Freedom J&J subsidi...

2026-03-06 14:58:14 ET More on Kenvue, GSK Kenvue: Out Of Favor Then, Under Pressure Now GSK: Post-Pivot Buoyancy Set To Continue After Strong 2025 (Upgrade) Kimberly-Clark: After The Kenvue Merger Vote, Ready To Rumble? CDC acting director calls for measles ...

2026-03-06 10:45:02 ET More on Pfizer, Merck, etc. Pfizer: Obesity Hype And Vaccine Policy Shocks AbbVie: Stabilizes Near $233 While Testing Resistance Pfizer's Portfolio Renewal In Progress - High Yields For The Patient China approves Pfizer’s GLP-1 d...

2026-03-05 16:02:27 ET More on dividend ETFs SCHD: When AI Hype Fades And Geopolitics Bite Vanguard Dividend Appreciation Index Fund ETF: Quality Discipline For Turbulent Times SCHD: Aren't You Glad You Didn't Sell? Yield strategies shine: Dividend funds deli...